Showing results (51-60 of 1,057) with videos related to
Sort By:
Pageof 106
Alzheimer'S & Dementia (New York, N. Y.)|March 1, 2021
Cerebral amyloid angiopathy distribution in older people: A cautionary noteVafa Alakbarzade, Jonathan Mr French, David R Howlett, et al.Alzheimer'S & Dementia (New York, N. Y.)|September 12, 2019
Key factors for the assessment of mobility in advanced dementia: A consensus approachKaren Van Ooteghem, Kristin E Musselman, Avril Mansfield, et al.Alzheimer'S & Dementia (New York, N. Y.)|November 3, 2018
Highly specific and selective anti-pS396-tau antibody C10.2 targets seeding-competent tauNina Rosenqvist, Ayodeji A Asuni, Christian R Andersson, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 20, 2018
Nuclear factor-kappa B: Glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease modelMythily Srinivasan, Niloy Lahiri, Anish Thyagarajan, et al.Alzheimer'S & Dementia (New York, N. Y.)|July 13, 2019
Tackling gaps in developing life-changing treatments for dementiaRui Mauricio, Caroline Benn, John Davis, et al.Alzheimer'S & Dementia (New York, N. Y.)|September 12, 2022
The impact of training on communication quality during interpreter-mediated cognitive assessments: Study protocol for a randomized controlled trialBianca Brijnath, Erika Gonzalez, Jim Hlavac, et al.Alzheimer'S & Dementia (New York, N. Y.)|January 22, 2025
Unraveling the impact of blood RANKL and OPG levels on Alzheimer's disease: Independent of bone mineral density and inflammationXingzhi Guo, Wenzhi Shi, Juanjuan Lu, et al.Alzheimer'S & Dementia (New York, N. Y.)|January 22, 2025
Perspective: Minimally clinically important "symptomatic" benefit associated with disease modification resulting from anti-amyloid immunotherapyJohn Alam, Marwan N SabbaghAlzheimer'S & Dementia (New York, N. Y.)|January 17, 2025
Comparison of sample characteristics of Wisconsin Alzheimer's Disease Research Center participants with the Wisconsin state population-An evaluation of the recruitment effortYue Ma, Maria C Mora Pinzon, William R Buckingham, et al.Alzheimer'S & Dementia (New York, N. Y.)|January 6, 2025
The problem of multiple adjustments in the assessment of minimal clinically important differencesFabricio Ferreira de OliveiraPageof 106